Stand Up To Cancer takes new approach to multiple myeloma focusing on precursor conditions

(Entertainment Industry Foundation) A $10 million SU2C Dream Team will revolutionize treatment of multiple myeloma, through early detection of precursor conditions MGUS & SMM, before they turn into full-blown disease. Leader Irene Ghobrial, M.D., (Dana-Farber Cancer Institute) and co-leader Ivan M. Borrello, M.D., (Sidney Kimmel CCC, Johns Hopkins) will conduct a large-scale US population survey to discover biomarkers to help predict those with a high risk of progressing to multiple myeloma and ...